These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 10086638)

  • 1. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
    Ganger DR; Klapman JB; McDonald V; Matalon TA; Kaur S; Rosenblate H; Kane R; Saker M; Jensen DM
    Am J Gastroenterol; 1999 Mar; 94(3):603-8. PubMed ID: 10086638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful recanalization of portal vein thrombosis before liver transplantation using transjugular intrahepatic portosystemic shunt.
    Liatsos C; Vlachogiannakos J; Patch D; Tibballs J; Watkinson A; Davidson B; Rolles K; Burroughs AK
    Liver Transpl; 2001 May; 7(5):453-60. PubMed ID: 11349268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.
    Attwell A; Ludkowski M; Nash R; Kugelmas M
    Aliment Pharmacol Ther; 2004 Oct; 20(8):867-73. PubMed ID: 15479358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt.
    Kavanagh PM; Roberts J; Gibney R; Malone D; Hegarty J; McCormick PA
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1135-9. PubMed ID: 15377290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
    Khuroo MS; Al-Suhabani H; Al-Sebayel M; Al Ashgar H; Dahab S; Khan MQ; Khalaf HA
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
    Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
    Cruz E; Ascher NL; Roberts JP; Bass NM; Yao FY
    Clin Transplant; 2005 Aug; 19(4):501-6. PubMed ID: 16008595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with extensive occlusion of the hepatic veins].
    Wu XJ; Cao JM; Han JM; Li JS
    Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1029-32. PubMed ID: 17074238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
    Opitz T; Buchwald AB; Lorf T; Awuah D; Ramadori G; Nolte W
    Z Gastroenterol; 2003 May; 41(5):413-8. PubMed ID: 12772054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
    D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI
    Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis].
    Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ
    Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients.
    Bilbao JI; Elorz M; Vivas I; Martínez-Cuesta A; Bastarrika G; Benito A
    Cardiovasc Intervent Radiol; 2004; 27(5):474-80. PubMed ID: 15383850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome.
    Shaked A; Goldstein RM; Klintmalm GB; Drazan K; Husberg B; Busuttil RW
    Surg Gynecol Obstet; 1992 Jun; 174(6):453-9. PubMed ID: 1595020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.
    Panagiotou I; Kelekis DA; Karatza C; Nikolaou V; Mouyia V; Brountzos EN
    Hepatogastroenterology; 2007 Sep; 54(78):1813-6. PubMed ID: 18019724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Budd-Chiari syndrome and TIPS--twelve years' experience].
    Safka V; Hůlek P; Krajina A; Dulícek P; Fejfar T; Jirkovský V; Pozler O; Vańásek T
    Cas Lek Cesk; 2005; 144 Suppl 3():38-42. PubMed ID: 16335262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.
    Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Haagsma EB; Kuipers EJ; Janssen HL
    Am J Gastroenterol; 2006 Jan; 101(1):83-90. PubMed ID: 16405538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis.
    Van Ha TG; Hodge J; Funaki B; Lorenz J; Rosenblum J; Straus C; Leef J
    Cardiovasc Intervent Radiol; 2006; 29(5):785-90. PubMed ID: 16850140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.
    Olliff SP
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1151-4. PubMed ID: 17033433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.